Searched for
TRADE MARGIN RATIONALISATION
India needs policy predictability to speed up drug approvals and boost pharma innovation: OPPI DGAnil Matai from the Organisation of Pharmaceutical Producers of India emphasized the need for regulatory predictability. He noted that Indi...
Budget 2027: Will the government cut STT and offer tax relief on bonds? Here's what experts have to sayAhead of Budget 2027, there are discussions on potential tax reforms affecting both equities and bonds. Experts advocate for lowering Secur...
India keeps growth engine humming, but weak monsoon may slow GDP to 7.5%: ICRAIndia's GDP growth is projected to ease to 7.5% in Q2 FY27, a five-quarter low, from 7.8% in the previous quarter, ICRA said. Weak monsoon ...
FirstCry shares rally 13% to one-month high. Why JM Financial sees 55% upside even after cutting target priceFirstCry operator Brainbees Solutions surged 13% after reporting improved Q2 FY27 results, with revenue rising 14% and net loss narrowing 7...
18 patent applications for HIV drug lenacapavir may delay affordable generics in IndiaGilead Sciences has filed 18 patent applications in India for lenacapavir, raising concerns among patient groups. They argue these applicat...
Compulsory licensing of drugs only after exhausting all other measures: Department of Pharmaceuticals secretary Manoj JoshiThe government plans to address the high costs of innovative medicines by first negotiating prices. Compulsory licensing will be considered...
NPPA issues strict guidelines for trade margin rationalisation on 137 cancer drugs to benefit patientsThe National Pharmaceutical Pricing Authority has implemented strict monitoring of Trade Margin Rationalisation for certain anti-cancer dru...
Over 1,300 anti-cancer drugs to get cheaperIndia's National Pharmaceutical Pricing Authority is set to cap trade margins on anti-cancer drugs starting November 2026. The initiative a...
Cancer drug prices revised from today; patients may save Rs 3,540 crore annuallyThe government has revised the prices of 1,364 anti-cancer medicine formulations effective from November 9. This decision aims to limit tra...
Samvat 2083 stock picks: 10 ideas from India’s top brokerages for the next DiwaliBrokerages have identified 10 stocks across banking, defence, hospitality, quick commerce, consumption and manufacturing for Samvat 2083. K...
Consumer goods cos turn to cost cutting amid higher input prices to protect demand, revive volume growthThe cost-cutting comes amid an elevated input-price outlook flagged by several companies during recent earnings calls, due to high raw mate...
Cancer drug prices to fall by up to 96% from November 9; consumers set to save Rs 3,502 crore annuallyStarting November 9, consumers in India will benefit from significantly reduced prices on 137 anti-cancer drugs. The government has capped ...
NPPA updates list of reduced MRP of 1,085 anti-cancer drugsThe National Pharmaceutical Pricing Authority updated the maximum retail price for 1,085 anti-cancer medicines. This revision follows a pre...
Marico Q2 Results: Net profit jumps 31% YoY to Rs 550 crore, revenue rises 12%Marico reported a 31% YoY rise in Q2FY27 net profit to Rs 550 crore, while revenue grew 12% to Rs 3,897 crore. EBITDA increased 27%, margin...
NPPA list brings little relief: No price cut for 25% cancer drugsNearly one in four cancer drug packs in the NPPA’s revised price list will see no reduction in MRP, even as the overall average cut across ...
Anti-cancer medicines: How to protect the patient today without weakening India's healthcare capacity for tomorrowIndia should examine trade margins across medicines, medical devices and consumables using a common, scientifically credible method - not a...
Blue Star strengthens leadership as Q2 revenue jumps 21%, margins tightenBlue Star Ltd appointed Nithianand S and Senthil Thangam as key management personnel effective November 1, 2026. The company reported a 21%...
Cancer care can be cheaper: 6 steps to cut drug costsIndia has capped trade margins at 30% on 137 non-scheduled anti-cancer drugs to reduce treatment costs. Experts call for standardised care,...
No crackers, easy on the festival lightsFestival consumption in India is facing challenges due to rising input costs and cautious spending patterns. Companies are experiencing pre...
Panel to finalise cancer drugs for 30% trade margin cap; Rs 2,500 crore annual savings possibleAn expert group is finalizing the list of cancer medicines for a new trade margin cap. The government plans to implement a 30% cap to reduc...